Cargando…

Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study

OBJECTIVE: To investigate the association between personal history, anthropometric features and lifestyle characteristics and endometrial malignancy in women with abnormal vaginal bleeding. METHODS: Prospective observational cohort assessed by descriptive and multivariable logistic regression analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbakel, Jan Yvan, Heremans, Ruben, Wynants, Laure, Epstein, Elisabeth, De Cock, Bavo, Pascual, Maria Angela, Leone, Francesco Paolo Giuseppe, Sladkevicius, Povilas, Alcazar, Juan Luis, Van Pachterbeke, Catherine, Jokubkiene, Ligita, Fruscio, Robert, Bourne, Tom, Van Calster, Ben, Timmerman, Dirk, Van den Bosch, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546126/
https://www.ncbi.nlm.nih.gov/pubmed/35044676
http://dx.doi.org/10.1002/ijgo.14097
_version_ 1784804972865519616
author Verbakel, Jan Yvan
Heremans, Ruben
Wynants, Laure
Epstein, Elisabeth
De Cock, Bavo
Pascual, Maria Angela
Leone, Francesco Paolo Giuseppe
Sladkevicius, Povilas
Alcazar, Juan Luis
Van Pachterbeke, Catherine
Jokubkiene, Ligita
Fruscio, Robert
Bourne, Tom
Van Calster, Ben
Timmerman, Dirk
Van den Bosch, Thierry
author_facet Verbakel, Jan Yvan
Heremans, Ruben
Wynants, Laure
Epstein, Elisabeth
De Cock, Bavo
Pascual, Maria Angela
Leone, Francesco Paolo Giuseppe
Sladkevicius, Povilas
Alcazar, Juan Luis
Van Pachterbeke, Catherine
Jokubkiene, Ligita
Fruscio, Robert
Bourne, Tom
Van Calster, Ben
Timmerman, Dirk
Van den Bosch, Thierry
author_sort Verbakel, Jan Yvan
collection PubMed
description OBJECTIVE: To investigate the association between personal history, anthropometric features and lifestyle characteristics and endometrial malignancy in women with abnormal vaginal bleeding. METHODS: Prospective observational cohort assessed by descriptive and multivariable logistic regression analyses. Three features—age, body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters), and nulliparity—were defined a priori for baseline risk assessment of endometrial malignancy. The following variables were tested for added value: intrauterine contraceptive device, bleeding pattern, age at menopause, coexisting diabetes/hypertension, physical exercise, fat distribution, bra size, waist circumference, smoking/drinking habits, family history, use of hormonal/anticoagulant therapy, and sonographic endometrial thickness. We calculated adjusted odds ratio, optimism‐corrected area under the receiver operating characteristic curve (AUC), R(2), and Akaike's information criterion. RESULTS: Of 2417 women, 155 (6%) had endometrial malignancy or endometrial intraepithelial neoplasia. In women with endometrial cancer median age was 67 years (interquartile range [IQR] 56–75 years), median parity was 2 (IQR 0–10), and median BMI was 28 (IQR 25–32). Age, BMI, and parity produced an AUC of 0.82. Other variables marginally affected the AUC, adding endometrial thickness substantially increased the AUC in postmenopausal women. CONCLUSION: Age, parity, and BMI help in the assessment of endometrial cancer risk in women with abnormal uterine bleeding. Other patient information adds little, whereas sonographic endometrial thickness substantially improves assessment.
format Online
Article
Text
id pubmed-9546126
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95461262022-10-14 Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study Verbakel, Jan Yvan Heremans, Ruben Wynants, Laure Epstein, Elisabeth De Cock, Bavo Pascual, Maria Angela Leone, Francesco Paolo Giuseppe Sladkevicius, Povilas Alcazar, Juan Luis Van Pachterbeke, Catherine Jokubkiene, Ligita Fruscio, Robert Bourne, Tom Van Calster, Ben Timmerman, Dirk Van den Bosch, Thierry Int J Gynaecol Obstet Clinical Articles OBJECTIVE: To investigate the association between personal history, anthropometric features and lifestyle characteristics and endometrial malignancy in women with abnormal vaginal bleeding. METHODS: Prospective observational cohort assessed by descriptive and multivariable logistic regression analyses. Three features—age, body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters), and nulliparity—were defined a priori for baseline risk assessment of endometrial malignancy. The following variables were tested for added value: intrauterine contraceptive device, bleeding pattern, age at menopause, coexisting diabetes/hypertension, physical exercise, fat distribution, bra size, waist circumference, smoking/drinking habits, family history, use of hormonal/anticoagulant therapy, and sonographic endometrial thickness. We calculated adjusted odds ratio, optimism‐corrected area under the receiver operating characteristic curve (AUC), R(2), and Akaike's information criterion. RESULTS: Of 2417 women, 155 (6%) had endometrial malignancy or endometrial intraepithelial neoplasia. In women with endometrial cancer median age was 67 years (interquartile range [IQR] 56–75 years), median parity was 2 (IQR 0–10), and median BMI was 28 (IQR 25–32). Age, BMI, and parity produced an AUC of 0.82. Other variables marginally affected the AUC, adding endometrial thickness substantially increased the AUC in postmenopausal women. CONCLUSION: Age, parity, and BMI help in the assessment of endometrial cancer risk in women with abnormal uterine bleeding. Other patient information adds little, whereas sonographic endometrial thickness substantially improves assessment. John Wiley and Sons Inc. 2022-02-07 2022-10 /pmc/articles/PMC9546126/ /pubmed/35044676 http://dx.doi.org/10.1002/ijgo.14097 Text en © 2022 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Articles
Verbakel, Jan Yvan
Heremans, Ruben
Wynants, Laure
Epstein, Elisabeth
De Cock, Bavo
Pascual, Maria Angela
Leone, Francesco Paolo Giuseppe
Sladkevicius, Povilas
Alcazar, Juan Luis
Van Pachterbeke, Catherine
Jokubkiene, Ligita
Fruscio, Robert
Bourne, Tom
Van Calster, Ben
Timmerman, Dirk
Van den Bosch, Thierry
Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study
title Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study
title_full Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study
title_fullStr Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study
title_full_unstemmed Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study
title_short Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study
title_sort risk assessment for endometrial cancer in women with abnormal vaginal bleeding: results from the prospective ieta‐1 cohort study
topic Clinical Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546126/
https://www.ncbi.nlm.nih.gov/pubmed/35044676
http://dx.doi.org/10.1002/ijgo.14097
work_keys_str_mv AT verbakeljanyvan riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT heremansruben riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT wynantslaure riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT epsteinelisabeth riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT decockbavo riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT pascualmariaangela riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT leonefrancescopaologiuseppe riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT sladkeviciuspovilas riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT alcazarjuanluis riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT vanpachterbekecatherine riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT jokubkieneligita riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT frusciorobert riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT bournetom riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT vancalsterben riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT timmermandirk riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT vandenboschthierry riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy
AT riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy